These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 11901238)

  • 1. Evolution of white matter lesions.
    Schmidt R; Schmidt H; Kapeller P; Lechner A; Fazekas F
    Cerebrovasc Dis; 2002; 13 Suppl 2():16-20. PubMed ID: 11901238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Slow progression of white-matter changes.
    Schmidt R; Schmidt H; Kapeller P; Fazekas F
    Int Psychogeriatr; 2003; 15 Suppl 1():173-6. PubMed ID: 16191236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MRI white matter hyperintensities: three-year follow-up of the Austrian Stroke Prevention Study.
    Schmidt R; Fazekas F; Kapeller P; Schmidt H; Hartung HP
    Neurology; 1999 Jul; 53(1):132-9. PubMed ID: 10408549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The natural course of MRI white matter hyperintensities.
    Schmidt R; Schmidt H; Kapeller P; Enzinger C; Ropele S; Saurugg R; Fazekas F
    J Neurol Sci; 2002 Nov; 203-204():253-7. PubMed ID: 12417393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors and progression of small vessel disease-related cerebral abnormalities.
    Schmidt R; Fazekas F; Enzinger C; Ropele S; Kapeller P; Schmidt H
    J Neural Transm Suppl; 2002; (62):47-52. PubMed ID: 12456049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal change of white matter abnormalities.
    Schmid R; Roob G; Kapeller P; Schmidt H; Berghold A; Lechner A; Fazekas F
    J Neural Transm Suppl; 2000; 59():9-14. PubMed ID: 10961412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MRI cerebral white matter lesions and paraoxonase PON1 polymorphisms : three-year follow-up of the austrian stroke prevention study.
    Schmidt R; Schmidt H; Fazekas F; Kapeller P; Roob G; Lechner A; Kostner GM; Hartung HP
    Arterioscler Thromb Vasc Biol; 2000 Jul; 20(7):1811-6. PubMed ID: 10894822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progression of cerebral white matter lesions: 6-year results of the Austrian Stroke Prevention Study.
    Schmidt R; Enzinger C; Ropele S; Schmidt H; Fazekas F;
    Lancet; 2003 Jun; 361(9374):2046-8. PubMed ID: 12814718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progression of cerebral white matter lesions -- clinical and radiological considerations.
    Enzinger C; Fazekas F; Ropele S; Schmidt R
    J Neurol Sci; 2007 Jun; 257(1-2):5-10. PubMed ID: 17321549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal magnetic resonance imaging vascular changes, apolipoprotein E genotype, and development of dementia in the neurocognitive outcomes of depression in the elderly study.
    Steffens DC; Potter GG; McQuoid DR; MacFall JR; Payne ME; Burke JR; Plassman BL; Welsh-Bohmer KA
    Am J Geriatr Psychiatry; 2007 Oct; 15(10):839-49. PubMed ID: 17623814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between Perivascular Spaces and Progression of White Matter Hyperintensities in Lacunar Stroke Patients.
    Loos CM; Klarenbeek P; van Oostenbrugge RJ; Staals J
    PLoS One; 2015; 10(9):e0137323. PubMed ID: 26352265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. White matter lesion progression in LADIS: frequency, clinical effects, and sample size calculations.
    Schmidt R; Berghold A; Jokinen H; Gouw AA; van der Flier WM; Barkhof F; Scheltens P; Petrovic K; Madureira S; Verdelho A; Ferro JM; Waldemar G; Wallin A; Wahlund LO; Poggesi A; Pantoni L; Inzitari D; Fazekas F; Erkinjuntti T;
    Stroke; 2012 Oct; 43(10):2643-7. PubMed ID: 22879094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High blood pressure and cerebral white matter lesion progression in the general population.
    Verhaaren BF; Vernooij MW; de Boer R; Hofman A; Niessen WJ; van der Lugt A; Ikram MA
    Hypertension; 2013 Jun; 61(6):1354-9. PubMed ID: 23529163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spontaneous white matter lesion in brain of stroke-prone renovascular hypertensive rats: a study from MRI, pathology and behavior.
    Fan Y; Lan L; Zheng L; Ji X; Lin J; Zeng J; Huang R; Sun J
    Metab Brain Dis; 2015 Dec; 30(6):1479-86. PubMed ID: 26387009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lesion probability maps of white matter hyperintensities in elderly individuals: results of the Austrian stroke prevention study.
    Enzinger C; Smith S; Fazekas F; Drevin G; Ropele S; Nichols T; Behrens T; Schmidt R; Matthews PM
    J Neurol; 2006 Aug; 253(8):1064-70. PubMed ID: 16607471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imaging of static brain lesions in vascular dementia: implications for clinical trials.
    Erkinjuntti T; Bowler JV; DeCarli CS; Fazekas F; Inzitari D; O'Brien JT; Pantoni L; Rockwood K; Scheltens P; Wahlund LO; Desmond DW
    Alzheimer Dis Assoc Disord; 1999; 13 Suppl 3():S81-90. PubMed ID: 10609686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deletion/insertion polymorphism of the angiotensin-converting enzyme gene and white matter hyperintensities in dementia: A pilot study.
    Purandare N; Oude Voshaar RC; Davidson Y; Gibbons L; Hardicre J; Byrne J; McCollum C; Jackson A; Burns A; Mann DM
    J Am Geriatr Soc; 2006 Sep; 54(9):1395-400. PubMed ID: 16970648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Telmisartan on top of antihypertensive treatment does not prevent progression of cerebral white matter lesions in the prevention regimen for effectively avoiding second strokes (PRoFESS) MRI substudy.
    Weber R; Weimar C; Blatchford J; Hermansson K; Wanke I; Möller-Hartmann C; Gizewski ER; Forsting M; Demchuk AM; Sacco RL; Saver JL; Warach S; Diener HC; Diehl A;
    Stroke; 2012 Sep; 43(9):2336-42. PubMed ID: 22738922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma level of sICAM-1 is associated with the extent of white matter lesion among asymptomatic elderly subjects.
    Han JH; Wong KS; Wang YY; Fu JH; Ding D; Hong Z
    Clin Neurol Neurosurg; 2009 Dec; 111(10):847-51. PubMed ID: 19825506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain atrophy accelerates cognitive decline in cerebral small vessel disease: the LADIS study.
    Jokinen H; Lipsanen J; Schmidt R; Fazekas F; Gouw AA; van der Flier WM; Barkhof F; Madureira S; Verdelho A; Ferro JM; Wallin A; Pantoni L; Inzitari D; Erkinjuntti T;
    Neurology; 2012 May; 78(22):1785-92. PubMed ID: 22592361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.